177 related articles for article (PubMed ID: 26048128)
1. [Not Available].
Vetter C
MMW Fortschr Med; 2015 Jun; 157 Suppl 2():56. PubMed ID: 26048128
[No Abstract] [Full Text] [Related]
2. Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies.
Gerussi A; D'Amato D; Cristoferi L; O'Donnell SE; Carbone M; Invernizzi P
Ann Hepatol; 2020; 19(1):5-16. PubMed ID: 31771820
[TBL] [Abstract][Full Text] [Related]
3. [New name and new treatments for primary biliary cholangitits].
Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
[TBL] [Abstract][Full Text] [Related]
4. Novel Aspects in the Management of Cholestatic Liver Diseases.
Chazouillères O
Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
[TBL] [Abstract][Full Text] [Related]
5. Novel and emerging therapies for cholestatic liver diseases.
Goldstein J; Levy C
Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
[TBL] [Abstract][Full Text] [Related]
6. Primary biliary cirrhosis in adults.
Momah N; Lindor KD
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):427-33. PubMed ID: 24580040
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
8. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
Levy C
Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
[TBL] [Abstract][Full Text] [Related]
9. Current Treatment Options for Primary Biliary Cholangitis.
Wong KA; Bahar R; Liu CH; Bowlus CL
Clin Liver Dis; 2018 Aug; 22(3):481-500. PubMed ID: 30259848
[TBL] [Abstract][Full Text] [Related]
10. Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid.
Lee YM; Kaplan MM
Curr Gastroenterol Rep; 1999; 1(1):38-41. PubMed ID: 10980925
[TBL] [Abstract][Full Text] [Related]
11. [Ursodeoxycholic acid: hope in the treatment of liver diseases].
Loizeau E
Rev Med Suisse Romande; 1994 Sep; 114(9):755-8. PubMed ID: 7939105
[No Abstract] [Full Text] [Related]
12. Obeticholic acid (Ocaliva) for primary biliary cholangitis.
Med Lett Drugs Ther; 2017 Mar; 59(1517):53-55. PubMed ID: 28323811
[No Abstract] [Full Text] [Related]
13. FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Alawad AS; Levy C
Dig Dis Sci; 2016 Dec; 61(12):3395-3404. PubMed ID: 27734248
[No Abstract] [Full Text] [Related]
14. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
15. Obeticholic Acid: First Global Approval.
Markham A; Keam SJ
Drugs; 2016 Aug; 76(12):1221-6. PubMed ID: 27406083
[TBL] [Abstract][Full Text] [Related]
16. Novel Therapies on Primary Biliary Cirrhosis.
Czul F; Levy C
Clin Liver Dis; 2016 Feb; 20(1):113-30. PubMed ID: 26593294
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].
Stiehl A
Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002
[No Abstract] [Full Text] [Related]
18. [Ursodeoxycholic acid--a new therapy concept in cholestatic liver diseases].
Raedsch R; Stiehl A
Klin Wochenschr; 1989 Feb; 67(4):265-8. PubMed ID: 2648062
[No Abstract] [Full Text] [Related]
19. [Bile acid therapy; new hope for patients with chronic liver diseases].
van Berge Henegouwen GP; van Erpecum KJ
Ned Tijdschr Geneeskd; 1991 Apr; 135(16):696-700. PubMed ID: 2038392
[No Abstract] [Full Text] [Related]
20. Obeticholic acid for the treatment of primary biliary cirrhosis.
Trivedi PJ; Hirschfield GM; Gershwin ME
Expert Rev Clin Pharmacol; 2016; 9(1):13-26. PubMed ID: 26549695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]